The Rhumbline Advisers Raises its position in Biogen Inc. (BIIB) as a favorable investment target.
The fund owned 357,364 shares of the biotechnology company’s stock after buying an additional 8,533 shares during the period. Rhumbline Advisers’Â …
The fund owned 357,364 shares of the biotechnology company’s stock after buying an additional 8,533 shares during the period. Rhumbline Advisers’Â …